Case 1:  Current Treatments and Best Opportunities
        
for a forthcoming first-in-class treatment                
Case 2:  Move from Pre-Launch to Blockbuster
         in a crowded market
Case 3:  Competitive Landscape of Usage Tracking
         plus demand-forecasting updates & support

Case 4:  Mapping Patient Flow and Dosing Stage
               of a drug for a target condition

© 2014-2017 Clarity Pharma Research LLC  |  All Rights Reserved Privacy Policy
To learn more about our services, call (864) 208-0078 or contact information@claritypharma.com.
Subscribe to our newsletter at: http://eepurl.com/ovQcb

THE ONLY PROVIDER OF SCIENTIFICALLY VALID PATIENT CHART AUDIT / TREATING PHYSICIAN RESEARCH

Case Study 5 
 
5-nation European patient records study shows lack of physician adherence to treatment guidelines
 

Situation:
Often our clients do not know the degree to which physicians adhere to recommended treatment guidelines even when their company’s product would benefit from such adherence.  We provide accurate metrics on guideline adherence and the driving factors for following protocols, and we can do this not only in the United States but in other nations, as shown in this de-identified study of 5 European Union nations (certain outputs and labels also were altered to protect client confidentiality).  In the case study below, we found that although physicians reported they usually followed guidelines, actual chart data revealed underusage of the recommended treatment (click on image of poster below to view PDF).  To learn what another Clarity Pharma study showed about adherence to treatment guidelines for a disease in the US, click the abstract link here.